Here are seven things for spine surgeons to know for Thursday, May 23, 2013.

Medtronic's fourth quarter total reported revenue was $4.46 billion, up 3.8 percent from last year's $4.3 billion, though global spine revenue dipped slightly.

Santa Clara, Calif.-based Benvenue Medical completed the yearlong patient follow-up phase in the clinical trial of its Kiva vertebral compression fracture treatment.

Minneapolis-based Medtronic announced it will cut approximately 500 jobs at its Minnesota facilities and 2,000 jobs worldwide, according to a TwinCities.com report.

Eric Woodard, MD, board-certified neurosurgeon and chief medical officer of InVivo Therapeutics, will participate in an FDA trial of InVivo's implantable scaffold device for treatment of spinal cord injuries, according to a wbur report.

This article is written by Bryan McEntire, chief technology officer for Salt Lake City-based Amedica.

Lewisville, Texas-based Orthofix International's gross profits dipped in the first quarter, down 17 percent from 2012's first quarter due to substantial declines in spine and orthopedic implant sales.

Precision Spine has named Tony Dimun as special business development, merger and acquisitions adviser and a member of the company's board of directors.

MAKO Surgical reported revenue of $24.8 million in the first quarter of 2013, a 26 percent increase over the same period last year.

King of Prussia, Pa.-based Trice Orthopedics has appointed Richard Washburn as President and raised $3 million in start-up capital.